Tag Archives: Eddingpharm

Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More

The road to every new drug approval is littered with the remains of earlier failures. Biopharmaceutical companies don’t like to talk about the failures. But it’s earnings season now, so some of them don’t have much choice. Biogen’s (NASDAQ: BIIB) earnings call this week was the first since its Alzheimer’s drug aducanumab failed in a Phase […]

Posted in Boston blog main, Boston top stories, Boulder/Denver blog main, Boulder/Denver top stories, Detroit blog main, Detroit top stories, Indiana blog main, Indiana top stories, National, National blog main, National top stories, New York blog main, New York top stories, Raleigh-Durham blog main, Raleigh-Durham top stories, San Diego blog main, San Diego top stories, San Francisco blog main, San Francisco top stories, Seattle blog main, Seattle top stories, Texas blog main, Texas top stories, Wisconsin blog main, Wisconsin top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More

Syndax Plots $69M IPO For Cancer Drug’s Stretch Run

Syndax Pharmaceuticals raised about $27 million in private financing last year to gear up for a late-stage clinical trial. Now, on the doorstep of that lengthy, 600-patient study, the Waltham, MA-based company is looking to Wall Street to get it to the finish line. Syndax late Thursday revealed plans to raise up to $69 million […]

Posted in Boston, Boston blog main, National blog main, San Diego blog main | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on Syndax Plots $69M IPO For Cancer Drug’s Stretch Run

East Coast Life Sciences Roundup: Aileron, Enzymatics, Acton, & More

[Updated, 8:15 a.m. ET] Labor Day has come and gone, and that means one thing: football season is finally upon us. But before the pigskins start flying en masse on Sunday, make sure to catch up on all your East Coast biotech news below: —Many drugmakers have tried, and failed, to find ways to protect […]

Posted in Boston, Boston blog main, National blog main | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on East Coast Life Sciences Roundup: Aileron, Enzymatics, Acton, & More